Cargando…

Prognostic Factors and Long-term Surgical Outcomes for Exudative Age-related Macular Degeneration with Breakthrough Vitreous Hemorrhage

PURPOSE: We sought to evaluate the long-term outcomes for patients with exudative age-related macular degeneration (AMD) undergoing vitrectomy for breakthrough vitreous hemorrhage and to investigate possible prognostic factors. METHODS: Consecutive patients treated at two high-volume referral-based...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Tae Young, Kang, Hyun Goo, Choi, Eun Young, Koh, Hyoung Jun, Kim, Sung Soo, Lee, Ji Hwan, Kim, Min, Byeon, Suk Ho, Lee, Christopher Seungkyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Ophthalmological Society 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419239/ https://www.ncbi.nlm.nih.gov/pubmed/32783420 http://dx.doi.org/10.3341/kjo.2020.0014

Ejemplares similares

Risk factors for breakthrough vitreous hemorrhage after intravitreal anti-VEGF injection in age-related macular degeneration with submacular hemorrhage
por: Shin, Yong-Il, et al.
Publicado: (2018)

Visual outcomes of early and late vitrectomy for breakthrough vitreous hemorrhage associated with exudative age-related macular degeneration and polypoidal choroidal vasculopathy
por: Jirarattanasopa, Pichai, et al.
Publicado: (2023)

Long-term Clinical Course after Vitrectomy for Breakthrough Vitreous Hemorrhage Secondary to Neovascular Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy
por: Kim, Jae Hui, et al.
Publicado: (2020)

Proteomics of Vitreous Humor of Patients with Exudative Age-Related Macular Degeneration
por: Koss, Michael Janusz, et al.
Publicado: (2014)

Pigmentary abnormality without significant drusen as a risk factor for late age-related macular degeneration
por: Lee, Junwon, et al.
Publicado: (2022)

Risk factors for breakthrough vitreous hemorrhage after intravitreal tissue plasminogen activator and gas injection for submacular hemorrhage associated with age related macular degeneration
por: Lim, Jun Hyun, et al.
Publicado: (2020)

Delayed vitreous prolapse after cataract surgery: clinical features and surgical outcomes
por: Kim, Tae Young, et al.
Publicado: (2021)

Clinical characteristics, risk factors, and surgical outcomes of secondary macular hole after vitrectomy
por: Kang, Hyun Goo, et al.
Publicado: (2019)

Vitreous hemorrhage as the presenting feature of peripheral exudative hemorrhagic chorioretinopathy in Indian eyes
por: Goel, Neha
Publicado: (2019)

Predictive Factors for Long-Term Outcomes of Cataract Surgery in Patients Receiving Active Treatment for Neovascular Age-Related Macular Degeneration
por: Choi, Eun Young, et al.
Publicado: (2021)

Vitreous Fatty Amides and Acyl Carnitines Are Altered in Intermediate Age-Related Macular Degeneration
por: Yoon, Chang-Ki, et al.
Publicado: (2023)

Breakthrough vitreous hemorrhage after ICGA guided PDT for PCV
por: Rishi, Pukhraj, et al.
Publicado: (2009)

Next-Generation Sequencing of Vitreoretinal Lymphoma by Vitreous Liquid Biopsy: Diagnostic Potential and Genotype/Phenotype Correlation
por: Kwak, Jay Jiyong, et al.
Publicado: (2023)

Changes in inner retinal layer thickness in patients with exudative age-related macular degeneration during treatment with anti-vascular endothelial growth factor
por: Lee, Seong Woo, et al.
Publicado: (2020)

Clinical Outcomes of Eyes with Submacular Hemorrhage Secondary to Age-related Macular Degeneration Treated with Anti-vascular Endothelial Growth Factor
por: Kim, Kun Hae, et al.
Publicado: (2015)

Characteristics of the inner retinal layer in the fellow eyes of patients with unilateral exudative age-related macular degeneration
por: Lee, Seong Eun, et al.
Publicado: (2020)

Infantile Vitreous Hemorrhage as the Initial Presentation of X-linked Juvenile Retinoschisis
por: Lee, Jong Joo, et al.
Publicado: (2009)

Change of retinal pigment epithelial atrophy after anti-vascular endothelial growth factor treatment in exudative age-related macular degeneration
por: Kim, Moosang, et al.
Publicado: (2016)

Intravitreal Anti-vascular Endothelial Growth Factor for Typical Exudative Age-related Macular Degeneration in Eyes with Good Baseline Visual Acuity
por: Chang, Young Suk, et al.
Publicado: (2014)

Short-term Efficacy and Safety of Intravitreal Brolucizumab Injection for Treatment-Naive Exudate Age-related Macular Degeneration: A Multicenter Study
por: Kim, Juno, et al.
Publicado: (2023)

Therapeutic Modalities of Exudative Age-related Macular Degeneration
por: Mavija, Milka, et al.
Publicado: (2014)

Clinical features and outcomes of breakthrough vitreous hemorrhage secondary to polypoidal choroidal vasculopathy
por: Li, Meng-Syuan, et al.
Publicado: (2022)

The Efficacy of Intravitreal Aflibercept in Submacular Hemorrhage Secondary to Wet Age-related Macular Degeneration
por: Shin, Kyung-Hoon, et al.
Publicado: (2016)

Long-Term Outcome of Eyes with Vitrectomy for Submacular and/or Vitreous Hemorrhage in Neovascular Age-Related Macular Degeneration
por: Kawakami, Setsuko, et al.
Publicado: (2021)

Development of Submacular Hemorrhage in Neovascular Age-related Macular Degeneration: Influence on Visual Prognosis in a Clinical Setting
por: Chang, Young Suk, et al.
Publicado: (2018)

Neovascular age-related macular degeneration without exudative recurrence over 24 months after initial remission
por: Cho, Han Joo, et al.
Publicado: (2022)

An Assessment of Vitreous Degeneration in Eyes with Vitreomacular Traction and Macular Holes
por: Ghadiali, Quraish, et al.
Publicado: (2017)

Early Signs of Exudative Age-Related Macular Degeneration in Asians
por: Sasaki, Mariko, et al.
Publicado: (2014)

Treatment of Exudative Age-related Macular Degeneration: Focus on Aflibercept
por: García-Layana, Alfredo, et al.
Publicado: (2015)

Unusual visual loss in a patient with exudative macular degeneration
por: Peng, Enoch T., et al.
Publicado: (2022)

Acute-Onset Vitreous Hemorrhage of Unknown Origin before Vitrectomy: Causes and Prognosis
por: Kim, Dong Yoon, et al.
Publicado: (2015)

Genome surgery using Cas9 ribonucleoproteins for the treatment of age-related macular degeneration
por: Kim, Kyoungmi, et al.
Publicado: (2017)

Efficacy of Intravitreal Triamcinolone Acetonide for Eyes with Postvitrectomy Diabetic Vitreous Hemorrhage
por: Lee, Sun Young, et al.
Publicado: (2007)

Anti-vascular Endothelial Growth Factor Treatment of Retinopathy of Prematurity: Efficacy, Safety, and Anatomical Outcomes
por: Kang, Hyun Goo, et al.
Publicado: (2018)

Optical Coherence Tomography-Based Deep-Learning Models for Classifying Normal and Age-Related Macular Degeneration and Exudative and Non-Exudative Age-Related Macular Degeneration Changes
por: Motozawa, Naohiro, et al.
Publicado: (2019)

Depression and anxiety in age-related macular degeneration
por: Kim, Eung Suk, et al.
Publicado: (2016)

Effect of Intravitreal Bevacizumab Injection before Panretinal Photocoagulation on the Prevention of Macular Edema Aggravation in Proliferative Diabetic Retinopathy
por: Choi, Wungrak, et al.
Publicado: (2020)

The Past, Present, and Future of Exudative Age-Related Macular Degeneration Treatment
por: Barak, Yoreh, et al.
Publicado: (2012)

High-Density Lipoprotein Function in Exudative Age-Related Macular Degeneration
por: Pertl, Laura, et al.
Publicado: (2016)

Real-Life Data of Patients with Exudative Age-Related Macular Degeneration
por: Togac, Mesut, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p0ao4gmn7al8uj5l9jsi18gegn